Valuation : Carmat SA

Market Cap 61.46L 71.27L 58.18L 52.69L 98.85L 68Cr 99.38L 6.91Cr 2.66Cr 35Cr 2.68Cr 2.62Cr 109.48Cr P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 5.92Cr 6.87Cr 5.61Cr 5.08Cr 9.53Cr 656.56Cr 9.58Cr 67Cr 26Cr 333.68Cr 26Cr 25Cr 1.06TCr EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Current year 0.1
Extreme 0.099
0.1
1 year 0.1
Extreme 0.0962
0.14
3 years 0.08
Extreme 0.085
9.99
5 years 0.08
Extreme 0.085
31.7
10 years 0.08
Extreme 0.085
40.06
Manager TitleAgeSince
Chief Executive Officer 55 01/09/2016
Director of Finance/CFO - 12/12/2018
Chief Tech/Sci/R&D Officer - 01/04/2025
Director TitleAgeSince
Director/Board Member 55 -
Director/Board Member 68 02/01/2017
Director/Board Member 79 20/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
13/03/25 Sell

Chairman

13,43,333 2.3347%
13/03/25 Buy

Chairman

13,43,333 2.3347%
29/05/24 Buy

Director

13,43,333 4.6122%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-33.56%-98.53% 70.8L
+2.06%-10.53%-28.05%-4.83% 10TCr
-1.66%-4.13%-28.63%-5.48% 1.17TCr
-1.84%-7.26%+91.10%+124.86% 1TCr
-1.34%-3.93%-55.03%-71.49% 399.05Cr
-2.84%-6.02%-30.57%+30.74% 239.98Cr
+7.16%+17.48%-7.33%-67.49% 196.94Cr
+1.47%-6.79% - - 181.49Cr
-2.10%-3.88%-24.51%-29.82% 152.9Cr
Average +0.10%-3.39%-14.57%-15.26% 1.52TCr
Weighted average by Cap. +1.29%-10.17%-19.74%+2.22%

Financials

2023 2024
Net sales 38.37L 44.49L 36.33L 32.9L 61.72L 43Cr 62.05L 4.31Cr 1.66Cr 22Cr 1.67Cr 1.63Cr 68Cr 73.44L 85.16L 69.53L 62.96L 1.18Cr 81Cr 1.19Cr 8.25Cr 3.17Cr 41Cr 3.2Cr 3.13Cr 130.83Cr
Net income -5.39Cr -6.25Cr -5.1Cr -4.62Cr -8.66Cr -596.97Cr -8.71Cr -61Cr -23Cr -303.4Cr -23Cr -23Cr -959.63Cr -5.14Cr -5.96Cr -4.87Cr -4.41Cr -8.27Cr -569.56Cr -8.31Cr -58Cr -22Cr -289.46Cr -22Cr -22Cr -915.56Cr
Net Debt 4.96Cr 5.76Cr 4.7Cr 4.26Cr 7.98Cr 550.06Cr 8.03Cr 56Cr 21Cr 279.55Cr 22Cr 21Cr 884.23Cr 5.31Cr 6.16Cr 5.03Cr 4.55Cr 8.54Cr 588.45Cr 8.59Cr 60Cr 23Cr 299.06Cr 23Cr 23Cr 945.93Cr
Logo Carmat SA
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
153
  1. Stock Market
  2. Stocks
  3. ALCAR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!